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REVIEW OF THE TOXICOLOGICAL PROPERTIES OF PENTABORANE, 
DIBORANE, DECABORANE, AND BORIC ACID 
By Joseph M. Lamberti 
SUMMARY 
A review is presented on the toxicity of several boron hydrides and 
boric acid from available data in chemical and medical literature as well 
as from classified information of various military agencies. 
The boron hydrides are extremely toxic as compared with other chemi-
cals, and their modes of action within the human body are unknown. Pri-
mary effects of exposure include disturbance of the central nervous sys-
tem for pentaborane and decaborane and pulmonary edema and hemorrhage for. 
diborane. Prolonged exposures to these three compounds may cause damage 
to the kidneys and liver. 
Tentative maximum allowable concentration for continuous exposure 
is 0.5 and 1.0 parts per million for pentaborane and diborane, respec-
tively. The exposure concentration of decaborane lies midway between 
that of pentaborane and diborane. In a comparison, pentaborane is con-
sidered more toxic than hydrogen cyanide, while the toxicity of diborane 
may be compared with that of phosgene. 
Although boric acid has long been used as a mild antiseptic, recent 
literature indicates poisoning of the human body by boric acid and boric 
oxide. The reported lethal dose (ingestion) for adults is 15 to 20 grams 
and for children, 5 to 6 grams. Many of the fatal cases reported in the 
literature involve application of boric acid over large areas of the de-
nuded skin. Indications are that the boric acid is probably not absorbed 
through the intact skin but rapidly through the abraded skin. 
Data are also presented comparing the toxicity of these compounds 
with other common laboratory chemicals. Information concerning protec-
tion for personnel engaged in working directly with these compounds is 
briefly discussed.
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A review of the available literature on the toxicity of the boron 
hydrides as well as boric oxide was necessary for research programs in-
volving high-energy fuels at the NACA Lewis laboratory. A brief exami-
nation of the literature (ref. i) showed that the boron hydrides were 
toxic. There was a need, therefore, to compile a survey in terms under-
standable both to the chemist and the engineer working with these hazard-
ous materials. 
This report discusses the relative toxicities of the boron hydrides 
and .the specific toxicological effects of pentaborane, diborane, and 
decaborane, and reviews various phases of protection for personnel work-
ing directly with these compounds. Data are also presented on the tox-
icity of boric acid and boric oxide. 
When using the information described in this report, the following 
points should be observed: 
(1) The report is intended primarily for the chemist and the engi-
neer working directly with the boron hydrides. Consequently, detailed 
medical data, description, and terminology are avoided. A limited glos-
sary of general medical terms has been included in appendix A for 
convenience. 
(2) The present report is not intended to represent a complete, com-
prehensive treatise on the toxicity of the boron hydrides. The data were 
collected from pertinent reports in available chemical and medical lit-
erature. The original reference should always be consulted for any de-
tailed, specific information concerning any item discussed herein. 
(3) Isolated cases of boron hydride exposures are not reported as 
such, except in one or two cases. The generalizations made whenever 
possible may not be strictly accurate since some are based on relatively 
few cases. 
(4) Discussion of first-aid procedures or personnel protection is 
limited to those procedures followed at the Lewis laboratory. They are 
not to be construed as "official", but rather as "common sense" proce-
dures which have been found satisfactory at this laboratory. 
FACTORS INFLUENCING INTERPRETATION OF TOXICITY DATA 
There are many factors influencing toxicity that must be taken into 
consideration and some of the more important factors are discussed in the 
following paragraphs.
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Mode of Action and Effect of Exposure 
It is necessary to distinguish between mode of action and effect of 
exposure before a proper evaluation of the toxicity of a chemical is made. 
Mode of action is the mechanism by which a normal physiological function 
is disturbed by the toxic agent. Effect of exposure is the pathology 
which may result from this disturbance. For example, these two factors 
may be illustrated with a case of carbon monoxide poisoning (ref. 2). 
In normal respiration, oxygen combines with the hemoglobin of the blood 
to form oxyhemoglobin. This compound dissociates in the body into re-
duced hemoglobin and oxygen which is available for the tissues. In the 
mode of action of carbon monoxide poisoning, carbon monoxide combines 
with the hemoglobin at a rate 210 times faster than that of oxygen to 
form carboxyhemoglobin (the combination of carbon monoxide and hemoglo-
bin), a more stable compound than oxyhemoglobin. Consequently, the more 
carboxyhemoglobin that is present in the blood stream, the less oxyhemo-
globin would be formed for respiratory purposes. 
The effect of exposure to carbon monoxide poisoning is asphyxiation. 
The length and severity of exposure will determine the degree of damage 
to the nervous system and circulation. 
Method of Exposure 
A poisonous material may enter a human body intravenously, sub-
cutaneously, by ingestion, inhalation, or skin absorption. When a com-
parison between two chemicals is made, the same method of exposure should 
be used in both cases. Also, the method of exposure will, in most cases, 
determine whether the action of the' toxic agent will be of a local or 
systemic nature.
Acute and Chronic Effects 
An important question that cannot be easily answered is whether an 
exposure to a toxic agent in relatively large concentrations for short 
periods of time will produce the same physiological and pathological ef-
fect as exposures of smaller concentrations for longer periods of time. 
There are many factors which influence the final result, such as, con-
centration of the toxic agent, method of exposure, rate of distribution 
of the toxic agent within the body, chemical reactivity of the toxic agent 
within the blood stream, and rate of elimination of the toxic agent (ref. 
2). The following examples will illustrate these points. 
The halogenated hydrocarbons are extensively used as industrial 
solvents and refrigerants. Acute effects of exposure generally involve 
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irritating action on the resratory tract and., 
nervous system (ref. 2). However, the chronic 
liver and kidney damage (ref. 2).
if severe, on the central 
results of exposure may be 
Carbon tetrachloride has many uses as a solvent and cleaner. Poison-
ing by this chemical may not only cause pulmonary and cardiac disturbance 
but also injury to the kidney and liver (refs. 2 and 3). The toxicologi-
cal effects of this compound are probably not only due to the carbon 
tetrachloride molecule itself but also to its degradation products which 
form within the body, namely, hydrochloric acid and phosgene (ref. 3). 
Benzene is an important compound used throughout the chemical in-
dustry. Its toxicity is dependent on two important facts, its insolu-
bility in body fluids, and its excellent fat solvent properties. Since 
it is insoluble in the body fluids, equilibrium between the amount in 
the blood stream and the vapors in the air is rapidly attained; there-
fore, elimination is fairly rapid following a brief exposure. However, 
elimination is much slower after a long exposure because benzene is en-
trapped in the fatty tissues of the body (ref. 3). 
Personal Factors 
- As a general rule, infants and children are more susceptible 
to the effects of chemical poisoning than adults. For example, younger 
people are more apt to get boric acid poisoning than older people (ref. 4). 
Immunity. - A person may build up an immunity to certain toxic ma-
terials with repeated exposure to them. This tolerance depends on the 
chemical and particular physiological make-up of the individual. For 
example, it is believed that an immunity to chlorine can form by repeated 
exposures to low concentrations of it (ref. 2). 
Health. - Persons who are ill or have recuperated from a recent ill-
ness are more susceptible to chemical poisoning than persons enjoying good 
health. Carbon tetrachloride poisoning, for example, is more severe in 
people with a history of kidney or heart disease (ref. 3). 
Animal Experiments 
Certain phases of the current medical research programs involve 
laboratory animals. Care must be taken in the extrapolation of the re-
sults of these experiments to include humans. In addition to the pre-
ceding factors which influence the toxicity of any given compound, the 
species of animals used and sometimes the different strains of the same 
species affect the results of a toxicity study (ref. 5). 
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Detailed principles of general industrial hygiene and toxicology 
as well as specific toxicities for Individual chemicals are adequately 
described in the excellent texts and handbooks listed in references 2, 
3, and 5 to 8.
TOXICOLOGY OF BORON HYDRIDES AND BORIC ACID 
Important physical properties of pentaborane, diborane, and deca-
borane are listed in table I; a review of their toxicological effects is 
as follows:
Pentaborane 
Toxicity. - The mode of action of pentaborane within the human body 
is unknown refs. 9 and io). However, primary effects of exposure in-
volve the central nervous system (refs. 9 to 11); prolonged exposure may 
also cause damage to both the liver and the kidneys (ref. 10). Skin con-
tact with this compound causes a severe chemical burn; the effects of in-
gestion are unknown. The most frequent cause of dangerous exposure to 
this material is inhalation (ref. 9). 
The results of animal experimentation (ref. 9), obtained from inhala-
tion tests, show that pentaborane is more toxic than diborane and hydro-
gen cyanide. Ingestion tests (refs. 9, 10, 12, and 13) with laboratory 
animals show convulsions, coma, and finally death in a relatively short 
time. Further animal tests (ref. 13) show that the lethal dose (LD5O) 
for a 2-hour exposure with pentaborane was 14.1 parts per million for 
male mice and 19.5 parts per million for male rats. (The LD50 concen-
tration is that concentration in which 50 percent of the test animals 
died.) These same (ref. 13) studies indicate that there may be an accum-
ulative toxic effect build up in the rats with repeated subacute expo-
sures to this compound. Also, detoxification did not seem to occur with-
in the animal body when exposed to low concentrations. There is no 
Information available regarding the accumulative toxic or detoxification 
effects of pentaborane on humans. 
Symptomatolo r . - The first general symptoms shown are typical in 
many chemical exposure poisonings. These may include dizziness, blurred 
vision, nausea, fatigue, and nervousness (refs. 9 to 11). However, the 
more characteristic symptoms of a severe pentaborane exposure are the ab-
normal muscular contractions or twitching of any part of the body followed 
by convulsion and then coma (refs. 9 to 11). After the convulsion-coma 
state, difficult breathing, blue coloration of the skin, poor muscular co-
ordination, and Imperfect articulation of speech may be observed (ref. 11). 
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Blood chemistry. - In a s'udy (unpublished data compiled by Callery 
Chemical Company) .
 based on 14 cases of pentaborane exposure, the follow-
ing facts about blood chemistry were generally observed: 
(1) An elevation of nonprotein nitrogen and blood urea nitrogen 
(indication of kidney disorder) 
(2) A positive cepbalin-cholesterol test (indication of liver 
dysfunction) 
(3) A positive thymol tubidity test (indication of liver dysfunction 
also) 
(4) A rise of creatinine level (indication of kidney disorder) 
(5) A high leucocyte count (white blood cells) 
Urinalysis. - Based on the same 14 cases mentioned previously, the 
following urinalysis observations were noted: 
(1) Albumin strongly positive (indication of kidney disorder) 
(2) Low percentage of excretion of phenolsulfonphthalein dye 
(another indication of poor kidney function) 
(3) Sugar in relatively large amounts 
The significance of these medical terms and tests are explained in 
appendix A of this report which is followed by a discussion (appendix B) 
of a severe case of pentaborane poisoning. 
Diborane 
Toxicity. - Within the human body the mode of action of diborane is 
unknown (refs. 9 and. 10), but the primary effect of exposure is pulmonary 
irritation (ref. 9). Prolonged exposure to the material may also cause 
damage both to the kidney and liver (refs. 10 and 14). Ingestion and 
inhalation effects on humans are not definitely known; however, animal ex-
perimentation reveals that diborane compared with phosgene ranks below pen-
taborane and decaborane in its toxicological effects (refs. 9 and 10). 
Additional animal studies revealed pulmonary edema (presence of 
serous fluid in lung tissues) and hemorrhage, tracheal and lung conges-
tion, and liver and kidney damage (refs. 9 10, 14, and 15). The LD 
value for the rat is 50 parts per million for an exposure time of 4 hours 
(ref. 14).
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Symptomatology. - The symptoms of a diborane poisoning generally 
include respiratory disturbances and those of the familiar "metal fume 
fever" syndrome, which consists of shivering or shaking of the voluntary 
muscles followed by sweat and pallor of the skin (refs. 9, 10, and ii). 
Decaborane 
Available data show no cases of human exposure to decaborane alone 
(ref. io). Most of the information that is available and discussed in 
the following paragraphs is based largely on animal experimentation 
(refs. 9, 10, and 12 to 17). 
Toxicity. - In humans the mode of action of decaborane within the 
body is not understood (refs. 9 and 10). Available data (ref. 15) indi-
cate that it behaves somewhat like pentaborane, but to a lesser degree, 
in its toxicological effects. In general, toxicity studies show that 
recovery from pentaborane exposure is more rapid than from decaborane 
(ref. 12). Primary effects of exposure are disturbances of the central 
nervous system; prolonged exposure may cause liver and kidney damage 
(refs. 16 and 17). These same tests revealed corneal damage, hemorrhagic 
adrenal glands, and cardiovascular disturbances. A cumulative toxic ef-
fect may be exhibited by animals with repeated small exposures to deca-
borane. From the results of a study (ref. 13) laboratory tests generally 
indicated a cumulative toxic effect of decaborane. Also, detoxification 
did not occur within the animal body. There is no quantitative informa-
tion on the cumulative or detoxifying action of decaborane in humans. 
The LD50 concentration for mice was 36.5 parts per million for an 
exposure time of 4 hours. Death of the animals occurred within 24 hours 
after the exposure (ref. 12). 
Symptomato1or. - Symptoms exhibited by animals exposed to deca-
borane may be compared with those exhibited by animals exposed to penta-
borane (muscular incoordination, convulsions, and coma) (refs. 12, 13, 
16, and 17). Additional clinical observations (ref. 17) include increased 
red-blood-cell count and hematocrit (measure of the relative volume of the 
plasma to the volume of the red blood cells), and increased number and 
percentage of the polymorphonuclear white blood cells. 
Boric Acid 
Toxic effect on humans. - Boric acid has been used extensively in 
the past as a mild antiseptic; it has never been considered as an indus-
trial poison. However, the literature within recent years has reported 
several deaths from this compound not only by ingestion but also by ap-
plication over large areas of the denuded skin (refs. 4 and 18 to 24). 
CONFIDENTIAL
8	 C0NBNTIAL	 NACA RM E561113a 
In 86 recognized clinil cases of boron poisoning (including several 
methods of exposure and various age levels of patients) reported by ref-
erence 4, the mortality rate was about 50 percent. Infants seemed to be 
more susceptible to boron poisoning than adults. 
The most characteristic symptoms of boric acid poisoning are gastro-
intestinal disorders and the erythematous (redness of skin) rash. In 
severe cases disorders of the central nervous system are noticed also 
(ref. 9). Symptoms of poisoning may not occur for several days or weeks 
after intoxication (refs. 4 and 19). Also, these same investigators re-
port that boron may accumulate in the kidneys, liver, and brain. The 
reported lethal dose (ingestion) for adults is 15 to 20 grams and 5 to 6 
grains for children (ref. 8). 
Toxic effect on plants. - Boron is necessary for the normal growth 
of many of the common plants (refs. 25 to 28). However, little is known 
about its role in plant metabolism. Experiments show that amounts of 
boron beyond the actual need of the specific plant are definitely toxic. 
The toxicity varies with each individual plant. For instance, corn is 
injured by 0.1 parts per million, while cotton can tolerate up to 10 
parts per million of boron (refs. 4 and 27). Irrigation waters which 
contain 0.5 to 2.5 parts per million are toxic to citrus trees (ref. 27). 
Toxic effect on animals. - In the animals studied (ref. 4), boron 
was not essential to any function of mammalian tissues. The acute tox-
icity varied from 0.8 to 2.0 grams per kilogram of animal body weight. 
Boric acid was probably not absorbed through the intact skin, but rapidly 
through the abraded skin. These same tests also showed that boron ac-
cumulated in the brain, liver, and fatty tissues of the animal body after 
prolonged small doses or acute overdoses of boric acid. Repeated injec-
tions of boric acid did not affect the blood-forming system of these 
animals. 
Toxic effect on fish. - The literature is rather scarce concerning 
the toxicity of boron in fish. The results of one study (ref. 28) showed 
that the rainbow trout is definitely harmed by concentrations of 80,000 
parts per million of boric acid; whereas, concentrations of 6250 parts 
per million were fatal for the rudd within 18 hours. 
Safe concentrations in water supplies. - For domestic water supplies, 
boron limits of 20 to 30 parts per million (ref. 28) have been recommended. 
For irrigation waters, a boron limit of 0.4 to 0.5 parts per million (ref. 
28) was reported, since above this concentration some plants may be 
injured.
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COMPARISON OF TOXICITY OF BORON HYDRIDES WITH OTHER CHEMICALS 
In order to show some relation between the toxicity of the boron 
hydrides and other chemicals, figure 1 presents these chemicals in their 
order of toxicity. For convenience, a logarithmic scale is used. This 
comparison is based on the allowable working concentration in parts per 
million. The calculation of parts per million is explained in appendix 
A. It is assumed that these values are based on an 8-hour working day. 
The values shown in figure 1 were taken from volume II of reference 2. 
It should be stressed that these numerical values are not absolute. They 
are average values for the "average" person. Figure 1 shows how extremely 
toxic pentaborane, diborane, and decaborane are when compared with other 
chemicals.
PERSONNEL PROTECTION
Allowable Concentrations 
The median-detectable concentration (ref. 29) and the maximum-
allowable concentration (ref. 30) for pentaborane, diborane, and deca-
borane are listed as follows: 
Compound Median- Maximum-
detectable allowable 
concentration concentration, 
mg/cu in ppm ppm 
Pentaborane 2.5 0.97 0.5 
Diborane 3.7 3.27 1.0 
Decaborane .35 .07
Monitoring Devices 
Since maximum-allowable concentrations of pentaborane, diborane, and 
decaborane are extremely low, it is essential to have some sort of moni-
toring device for personnel protection. Monitoring devices and their 
feasibility are discussed in references 30 to 36. 
At the Lewis laboratory, the amperometric borane detector (ref. 31) 
and the hand-operated pentaborane detector (ref. 32) are used. -The am-
perometric borane detector built at Lewis according to the specifications 
in reference 31 can detect 1.5 to 2.0 parts per million of diborane. 
The hand-operated pentaborane detector can detect 1 to 2 parts per 
million.
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Since these monitoridevices detect concentrations above the per-
missible working levels, Lewis personnel, even if they are wearing gas 
masks, are instructed to leave work areas as soon as these detectors give 
an indication of. vapors in the atmosphere. 
Gas Masks 
Evaluation of gas-mask absorbents for pentaborane and.diborane is 
given in reference 37. In removing a 0.5-percent pentaborane concentra-
tion from. the air, Whetlerite and activated carbon proved ,
 satisfactory; 
activated alumina and zinc-chloride-impregnated alumina were poor. For 
diborane, the Mine Safety Appliance "All Service" or Model S canister was 
satisfactory in removing concentrations of diborane ranging from 0.5 to 
3 percent. However, no canister was satisfactory for diborane concen-
trations above the flammable' limits. 
Gas-mask protection against d.ecaborane is discussed in reference 17. 
In removing less than 0.01-percent decaborane concentration from the air, 
silica gel was the best absorbent; activated carbon was , also a good. 
absorbent. 
Air-supplied masks with full-face shields are always used at the 
Lewis laboratory by personnel entering work areas that may have high 
concentrations of these compounds. 
Wearing Apparel 
At the Lewis laboratory, personnel working directly with the boron 
hydrides wear the following apparel: 
(1) Chemical safety goggles and full face shields 
(2) Fireproof or leather jackets and trousers 
(3) Asbestos and/or rubber gloves 
(4) Masks as required 
TREATMENT FOR EXPOSURE TO BORON HYDRIDES 
Minor Exposure 
Workers who accidently spill small amounts of the boron hydrides .on 
their skin or into their eyes should thoroughly flush the affected parts 
of the body with water and promptly leave the contaminated area. The 
contaminated clothing should be removed and destroyed. 
CONFIDENTIAL
NACA RN E561113a	 -	 C0N14 '	 11 
Major Exposuré. 
Unfortunately, for major exposure no specific therapy is known for 
poisoning by any of the boron hydrides discussed in this report. At 
present, therapy can only be symptomatic. 
In cases of pentaborane and decaborane exposure where muscular 
twitching is noted, a short-term barbiturate can be used to control any 
impending convulsions. Barbiturates should be used with caution because 
of "synergic respiratory depression" (refs. 9 and 10). A late complica-
tion may be pulmonary edema, in which case, oxygen therapy should be 
used (refs. 9 and io). 
In cases of diborane poisoning, oxygen therapy should be used to 
help combat the pulmonary edema that may develop (refs. 9 and 10). 
In the case of the boron hydrides, there is no specific therapy 
known to combat boric 'acid poisoning. Symptomatic therapy (ref. 21) 
can include intravenous administration of fluids and plasma or blood, 
antibiotics, and possibly adrenal cortical extracts. 
SUMMARY 
The toxic properties of pentaborane, diborane, decaborane, and boric 
acid are summarized as follows: 
1. Effects of pentaborane exposure involve the central nervous 
system. Prolonged exposure may cause damage both to the kidneys and the 
liver. It is considered more toxic than diborane and hydrogen cyanide. 
2. Diborane poisoning causes pulmonary edema and hemorrhage. It 
can be compared with phosgene (a war-time poison gas), and is less toxic 
than pentaborane and decaborane in its effects. 
3. The accurate toxicological effects of decaborane are unknown 
but may be compared with those of pentaborane.-
4. Boron intoxication may occur from the absorption of boric oxide 
or boric acid by the broken skin of the body. Continued exposure may 
cause boron accumulation in the kidneys, liver, and brain. 
Lewis Flight Propulsion Laboratory 
National Advisory Committee for Aeronautics 
Cleveland, Ohio, August 21, 1956 
CONFIDENTIAL
12	 •®NFTIAL	 NACA RM E561113a 
APPENDIX A 
MEDICAL TERMS 
The medical terms used in this report are listed alphabetically 
and explained as follows (refs. 38 through 41): 
Albumin. - Albumin is a protein which, if detected in the urine, 
generally indicates a kidney dysfunction. 
Blood count. - The red blood cells (erythrocytes) are the oxygen 
1	 1. 
carriers of the blood. The normal count varies from 4 to 5 million and 
6 million per cubic millimeter for women and men, respectively. 
The white blood cells (leucocytes) have several functions, one of 
the most important being phagocytosis (ingestion and destruction of 
bacteria). The average count is 10,000 white cells per cubic millimeter. 
These cells may be subdivided as shown in the following table (ref. 40): 
Type of cell Percent Total number/ 
of cells cu iinn 
Neutrophils 60-70 4000-6000 
Basophils 0.5-1 50-100 
Eosinophils 1-3 100-300 
Lymphocytes 20-40 2000-4000 
Monocytes 2-6 200-600
Blood urea nitrogen (B.U.N.). - Urea is the end product of protein 
(nitro'genT metabolism. The normal range in the blood is 10 to 15 milli-
grams per 100 milliliters. High blood urea levels are present in in-
creased protein metabolism, toxic and febrile conditions, dehydration of 
the blood, and various kidney disorders (ref. 41). In extensive liver 
damage, the blood urea may fall below normal (ref. 41). 
Cephalin - cholesterol flocculation test. - The cephalin - cholesterol 
flocculation testis a test of liver function. The principle of the test 
consists in adding a mixture of cephalin cholesterol to a patient's serum. 
Flocculation (positive reaction) occurs in cases of liver dysfunction. 
Positive reactions may also be seen in nephritis associated with abnormal 
protein concentrations (ref. 40). 
Central nervous system. - The central nervous system is made up of 
the brain and spinal cord.
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Creatinine. - Creatinine is the end p.uct of creatine (amino acid.) 
metabolism and is a metabolite associated with energy metabolism in 
muscle physiology. Blood creatinine levels may be used as an index to 
the filtration power of the kidney. Elevated blood levels are found in 
severe kidney disorders. The normal blood creatinine range is 1 to 2 
milligrams per 100 milliliters of blood; the normal urinary level is 1 
to 1.2 grains per 24 hours (ref. 41). 
Nonprotein nitrogen (N.P.N.). - The nitrogeneous components and 
their normal levels (mg/100 ml of blood.) that make up the nonprotein-
nitrogen fraction of the blood are as follows (ref. 41): 
Blood components Mg/100 ml 
of blood 
Urea nitrogen 10-15 
Creatinine 1-2 
Uric acid. 2-3.5 
Creatine 3-7 
Amino acid nitrogen .5-8 
Ammonia nitrogen 0.1-0.2 
Undetermined nitrogen 4-10 
Total nonprotein 
nitrogen 25-35
The nonprotein nitrogen of the blood generally determines the fil-
tration power of the kidney; however, a small deviation from the normal 
level in a determination is not as significant as a deviation in the 
levels of such individual components as urea or creatinine. High 
nonprotein-nitrogen levels (nitrogenous retention) indicate functional 
disorders of the kidney. 
Parts per million. - The mathematical expression used to determine 
the concentration of a toxic agent in air is shown as (ref. 2, vol. I) 
24,450 X (mg/liter of toxic agent) 
Parts per million (Molecular weight of toxic agent) 
Phenolsulfonphthalein test. - The phenolsulfonphthalein test deter-
mines the excretory ability of the kidneys (ref. 42). A certain quantity 
of dye is injected intravenously into the patient, and the appearence time 
as well as the amount excreted are noted at various intervals. An in-
crease in appearance time and a decrease in excretory rate indicate kidney 
dysfunction (ref. 42).
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Polymorphonuclear whi111ood cells. - The polymorphonuclear white 
blood cells are blood cells which have nuclei of many forms. 
Semioliguria. - Semioliguria is the reduced daily output of urine. 
Thymol-turbidity test. - The thymol-turbidity test is a check of 
liver function. In the cases of liver dysfunction, turbidity (positive 
reaction) 'results when thymol reagent is added to the blood serum. 
CONFIDENTIAL
NACA RN E561113a	 COIFIDIE	 15
APPENDIX B 
PEIffABOR14.NE POISONING 
A severe pentaborane exposure as reported by the Callery Chemical 
Company (unpublished data) is summarized in part as follows: 
Syintoinato1or 
(1) Convulsions (severe after 2 hr) 
(2) Hiccoughs (began 12 hr after poisoning; lasted 1 week) 
(3) Memory disturbance (1 week from initial attack) 
(4) Fatigue(2 days, then gradual diminution) 
(5) Headache (lasting 2 weeks, old history also) 
(6) Nerve pain (right-ear area, peripheral neuritis) 
(7) Nausea (from exposure time to 5 days) 
(8) Semioliguria (3 to 6 days) 
(9) Temperature (99° to 1000 F) 
Physical Findings 
The physical findings after pentaborane exposure are normal except 
as follows: 
(1) Tachycardia on admission, lasting 24 hours; normal electro-
cardiogram (Tachycardia is the excessive rapidity in the ac-
tion of the heart, and electrocardiogram is a graphic tracing 
of the contraction of the heart muscle.) 
(2) Occipital neuritis posterior to the right ear (onset in 7 days; 
lasted 1 week)
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(3) Rise in the blood.ssure, which would read on admission, 
100/46; on the 4th to l8t11 day, 168/110 (observed when the 
nonprotein nitrogen and blood urea nitrogen were at their 
highest); on the 20th day, 138/100; and on the 34thday, 124/90. 
Blood Chemistry and Urinalysis 
Variations from the normal levels of several components of the blood 
as a function of time are shown in figure 2. It should be noted that 
there was a sharp increase in these blood components within 1 week after 
the exposure. After this rise they began to subside to normal levels. 
However, in the case of the cephalin-cholesterol flocculation test normal 
levels were not achieved for the time shown (fig. 2). 
Figure 2(b) shows the various tests performed on the urine of the 
same individual. Variations from the normal levels of these tests are 
plotted as a function of time. The greatest changes were noticed within 
1 week.
Hematology 
Pentaborane poisoning affects the blood analysis as shown by the 
following: 
(1) Hemoglobin (the normal value obtained depends on the method of 
determination; by the Sahli method, 13.8 g per 100 cc of blood) was 
present at its highest value as 13 grams and its lowest as 11.5 grams. 
(2)White blood count (normal value, 7000 to 10,000 cells per cc) 
was high with a reading of 32,000 and low with 7150. 
(3) Lymphocytes (a variety of the white blood corpuscles which make 
up 20 to 40 percent of the total white blood cell count) ranged from a 
high of 30 percent to a low of 21 percent. 
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TABLE 1a 
Name Formula Physical 
state
M.P., 
°C
B.P. 
°C
Stability Hydrolysis 
Diborane B2H6 Gas -165.6 -92.5 Fair Very fast 
Pentaborane B5H9 Liquid -46.8 58 Good. Slow 
Decaborane B10H14 Solid .99.5 213 Very good Very slow
aTaken from ref. 34.
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Ethyl chloride 
Propylene 
Hexane 
Turpentine 
Acetone 
Methylene chloride 
Diethyl ether 
Methyl formate 
Octane 
Heptane 
Toluene 
Nitromethane 
Methyl chloride 
Trichloroethylene 
Benzene 
Carbon tetrachloride 
Carbon monoxide 
Ethylene dichloride 
Chlorobenzene 
Nitrogen dioxide 
Hydrogen cyanide 
Hydrogen sulfide 
Carbon bi8ulfide 
Acetic acid 
Formic acid 
Formaldehyde 
Hydrogen chloride 
Aniline
Diborane 
Decaboranea 
Pentaborane 
.1-
Figure 1. - Comparison of allowable working con-
centrations, for an assumed 8-hour working period, 
of common laboratory chemicals with diborarie, 
decaborane, and pentaborane. 
aApproximate .
 The toxicity of decaborane is inter-
mediate between diborane and pentaborane. 
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